SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,993,357 | +61.8% | 527,343 | +186.8% | 0.00% | – |
| Q2 2023 | $1,231,862 | -64.6% | 183,860 | -65.6% | 0.00% | – |
| Q1 2023 | $3,483,853 | +69.6% | 535,154 | +122.3% | 0.00% | – |
| Q4 2022 | $2,053,563 | +42.9% | 240,746 | -11.5% | 0.00% | – |
| Q3 2022 | $1,437,000 | -46.4% | 272,100 | -57.0% | 0.00% | – |
| Q2 2022 | $2,680,000 | +1748.3% | 632,082 | +1426.8% | 0.00% | – |
| Q1 2022 | $145,000 | -82.1% | 41,400 | -66.1% | 0.00% | – |
| Q4 2021 | $812,000 | +497.1% | 122,000 | +797.1% | 0.00% | – |
| Q3 2021 | $136,000 | – | 13,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |